Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bi-Profenid 200 mg versus 300 mg non-inferiority study in acute musculoskeletal or acute non-infectious rheumatologic pain
2008-003375-41Phase 3Completed
- Sponsor
- Sanofi
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ketoprofen in Musculoskeletal pain and rheumatism (2 arms), sponsored by Sanofi. Primary endpoints: Change in pain intensity at rest from Day 1 to Day 5 and Total concomitant analgesic consumption over 5 days. Started Jul 2008; status: completed.
02
Drugs
ketoprofen
03
Conditions
Musculoskeletal painrheumatism
Beyond the preview
Go deeper on 2008-003375-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003375-41.